olodaterol hydrochloride · Boehringer Ingelheim · NDA 203108
Striverdi Respimat
Earliest generic entry, as listed
19 Jan 2027
Blocked by patent: US 7727984.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7727984 | substance | 19 Jan 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: patent · 203108-00119 Jan 2027
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203108 · 001 · RLD | spray, metered, inhalation | EQ 0.0025MG BASE/INH | 19 Jan 2027 |